Table 3.
Readings | I NYHA (n = 26) |
II NYHA (n = 78) |
III NYHA (n = 54) |
IV NYHA (n = 27) |
p Value |
---|---|---|---|---|---|
Platelet count × 109/L (mean ± SD) | 227.29 ± 54.52 | 222.83 ± 63.09 | 217.83 ± 55.29 | 218.95 ± 124.89 | 0.972 |
MPV, Fl (mean ± SD) | 9.25 ± 0.46 a | 9.65 ± 1.22 b | 9.78 ± 1.15 c | 10.75 ± 1.2 | <0.005 |
Leukocyte count × 109/L (mean ± SD) | 7.17 ± 2.11 | 7.10 ± 2.07 | 6.82 ± 1.83 | 7.31 ± 1.85 | 0.878 |
NEU, % (mean ± SD) | 58.65 ± 9.55 a | 62.61 ± 8.02 | 58.56 ± 10.35 c | 65.86 ± 8.99 | 0.034 |
NEU count × 109/L (mean ± SD) | 4.20 ± 1.32 | 4.52 ± 1.34 | 4.11 ± 1.64 c | 4.99 ± 1.73 | 0.028 |
LIMPHO, % (mean ± SD) | 28.53 ± 8.82 a | 24.48 ± 7.14 | 28.05 ± 9.66 c | 20.35 ± 6.15 | <0.009 |
LIMPHO count × 109/L (mean ± SD) | 2.09 ± 0.85 a | 1.70 ± 0.56 | 1.88 ± 0.59 c | 1.44 ± 0.40 | 0.005 |
MONO, % (mean ± SD) | 8.23 ± 1.84 a | 8.7 ± 2.77 | 8.90 ± 3.41 | 10.67 ± 3.63 | 0.045 |
MONO count × 109/L (mean ± SD) | 0.59 ± 0.21 a | 0.61 ± 0.25 | 0.60 ± 0.25 | 0.76 ± 0.27 | 0.014 |
ANOVA was used for comparisons. Note: a—statistically significant difference between NYHA I and NYHA IV patients; b—statistically significant difference between NYHA II and NYHA IV; c—statistically significant difference between NYHA IV and NYHA III. MPV—mean platelet volume; NEU—neutrophil; LIMPHO—lymphocyte; MONO—monocyte.